نتایج جستجو برای: cml

تعداد نتایج: 6124  

2011
Christian Hurtz Katerina Hatzi Leandro Cerchietti Melanie Braig Eugene Park Yong-mi Kim Sebastian Herzog Parham Ramezani-Rad Hassan Jumaa Martin C. Müller Wolf-Karsten Hofmann Andreas Hochhaus B. Hilda Ye Anupriya Agarwal Brian J. Druker Neil P. Shah Ari M. Melnick Markus Müschen

Chronic myeloid leukemia (CML) is induced by the oncogenic BCR-ABL1 tyrosine kinase and can be effectively treated for many years with tyrosine kinase inhibitors (TKIs). However, unless CML patients receive life-long TKI treatment, leukemia will eventually recur; this is attributed to the failure of TKI treatment to eradicate leukemia-initiating cells (LICs). Recent work demonstrated that FoxO ...

2014
Young Jae Byun Byeong-Bae Park Eun Sung Lee Kyung Soo Choi Dae Sung Lee

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by overproduction of myeloid white blood cells. Philadelphia chromosome is an essential finding for CML diagnosis. Generally, a clinical diagnosis of essential thrombocythemia (ET) can be established from isolated marked thrombocytosis in peripheral blood. However, Philadelphia chromosome-positivity or bcr/abl rearran...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2014
Katrien H J Gaens Gijs H Goossens Petra M Niessen Marleen M van Greevenbroek Carla J H van der Kallen Hans W Niessen Sander S Rensen Wim A Buurman Jan Willem M Greve Ellen E Blaak Marc A van Zandvoort Angelika Bierhaus Coen D A Stehouwer Casper G Schalkwijk

OBJECTIVE Dysregulation of inflammatory adipokines by the adipose tissue plays an important role in obesity-associated insulin resistance. Pathways leading to this dysregulation remain largely unknown. We hypothesized that the receptor for advanced glycation end products (RAGE) and the ligand N(ε)-(carboxymethyl)lysine (CML) are increased in adipose tissue and, moreover, that activation of the ...

Journal: :Blood 2011
Peter C Trask David Cella Christine Powell Arlene Reisman Jennifer Whiteley Virginia Kelly

The increased survival associated with treatments for CML emphasize the importance of understanding the HRQOL of newly diagnosed and previously treated CML patients with all phases of disease. Functional Assessment of Cancer Therapy-Leukemia results from a phase 3 and a phase 2 trial are reported for over 900 1st, 2nd, 3rd line CP, AP, and BP patients. Physical Well-being and Leukemia symptoms ...

Journal: :Internal medicine 2010
Hidetoshi Sumimoto Hideki Tsujimura Mikiko Ise Naoya Mimura Chikara Sakai Toshiyuki Takagi Kyoya Kumagai

Chronic myeloid leukemia (CML) is generally diagnosed in the chronic phase. We have recently encountered two CML-blastic phase (BP) cases, a 71-year-old woman and a 74-year-old man, who resembled de novo acute leukemia. The complete blood count was normal at least 11 and 13 months before the presentation, respectively. The leukemic cells showed predominant lymphoid phenotype. The blasts and gra...

2015
Bailing Zu Yi Shi Min Xu Guoling You Zhenglan Huang Miao Gao Wenli Feng

BACKGROUND Treatment of blast phase chronic myeloid leukemia (BP-CML) remains a challenge, and the median survival is less than 6 months. Because effective treatments are lacking, we studied tight targeting of blast crisis CML cells using adenoviral (Ad) vectors expressing a HSV-TK system under dual control of a specific SUZ12 promoter and an antioxidant response element (ARE). METHODS A pote...

2003
Payam Heydari Ravindran Mohanavelu

A comprehensive study of ultra high-speed current-mode logic (CML) buffers and regenerative CML latches will be illustrated. A new design procedure to systematically design a chain of tapered CML buffers is proposed. Next, a new 20GHz regenerative latch circuit will be introduced. Experimental results show a higher performance for the new latch architecture compared to a conventional CML latch ...

2015
Mabel Lardo Marcelo Castro Beatriz Moiraghi Francisca Rojas Natalia Borda Jorge A Rey Alberto Lazarowski

BACKGROUND Tyrosine kinase inhibitors (TKIs) are the recommended treatment for patients with chronic myeloid leukemia (CML). The MDR1/ABCB1 gene plays a role in resistance to a wide spectrum of drugs, including TKIs. However, the association of MDR1/ABCB1 gene polymorphisms (SNPs) such as C1236T, G2677T/A, and C3435T with the clinical therapeutic evolution of CML has been poorly studied. We inv...

Journal: :Siriraj Medical Journal 2022

Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of Philadelphia chromosome and BCR-ABL fusion oncogene. CML one illnesses that may be treated using Tyrosine Kinase Inhibitors (TKIs), type targeted therapy. Since TKIs are standard therapy, long-term survival has improved compared to chemotherapy interferon-alpha. For first-line treatment for CML, the...

Journal: :The journal of media literacy education 2022

Critical media literacy (CML) is vital for students to navigate the current proliferation of misinformation and disinformation. Despite what known about influence teacher beliefs on classroom practice, little research date has looked at teachers perceive importance CML. The researchers administered a survey throughout U.S. (N = 362) their perceptions teaching CML as part instruction. Using quan...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید